Comparison of thalidomide and lenalidomide as therapy for myelofibrosis
Jabbour, Elias, Thomas, Deborah, Kantarjian, Hagop, Zhou, Lingsha, Pierce, Sherry, Cortes, Jorge, Verstovsek, Srdan
Published in Blood (28.07.2011)
Published in Blood (28.07.2011)
Get full text
Journal Article
Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study
Bose, Prithviraj, Masarova, Lucia, Pemmaraju, Naveen, Bledsoe, Sharon D, Daver, Naval G, Jabbour, Elias J, Kadia, Tapan M, Estrov, Zeev, Kornblau, Steven M, Andreeff, Michael, Jain, Nitin, Cortes, Jorge E, Borthakur, Gautam, Alvarado, Yesid, Richie, Mary Ann, Dobbins, Mackenzie H, McCrackin, Selene A, Zhou, Lingsha, Pierce, Sherry A, Wang, Xuemei, Pike, Allison M, Garcia-Manero, Guillermo, Kantarjian, Hagop M, Verstovsek, Srdan
Published in Haematologica (Roma) (01.08.2024)
Published in Haematologica (Roma) (01.08.2024)
Get full text
Journal Article
Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
TAM, Constantine S, KANTARJIAN, Hagop, CORTES, Jorge, LYNN, Alice, PIERCE, Sherry, LINGSHA ZHOU, KEATING, Michael J, THOMAS, Deborah A, VERSTOVSEK, Srdan
Published in Journal of clinical oncology (20.11.2009)
Published in Journal of clinical oncology (20.11.2009)
Get full text
Journal Article
Ruxolitinib in combination with lenalidomide as therapy for patients with myelofibrosis
Daver, Naval, Cortes, Jorge, Newberry, Kate, Jabbour, Elias, Zhou, Lingsha, Wang, Xuemei, Pierce, Sherry, Kadia, Tapan, Sasaki, Koji, Borthakur, Gautam, Ravandi, Farhad, Pemmaraju, Naveen, Kantarjian, Hagop, Verstovsek, Srdan
Published in Haematologica (Roma) (01.08.2015)
Published in Haematologica (Roma) (01.08.2015)
Get full text
Journal Article
P1025: A PILOT STUDY OF THE ANTI‐SLAMF7 MONOCLONAL ANTIBODY, ELOTUZUMAB, IN PATIENTS WITH MYELOFIBROSIS
Bose, Prithviraj, Masarova, Lucia, Pemmaraju, Naveen, Dobbins, Mackenzie, Jain, Nitin, Abbas, Hussein, Kornblau, Steven, Maiti, Abhishek, Veletic, Ivo, Manshouri, Taghi, Bledsoe, Sharon, Ann Richie, Mary, Hall‐Moore, Nakiuda, Zhou, Lingsha, Wang, Xuemei, Kantarjian, Hagop, Estrov, Zeev, Verstovsek, Srdan
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Improved survival of patients with myelofibrosis in the last decade: Single‐center experience
Masarova, Lucia, Bose, Prithviraj, Pemmaraju, Naveen, Daver, Naval G., Sasaki, Koji, Chifotides, Helen T., Zhou, Lingsha, Kantarjian, Hagop M., Estrov, Zeev, Verstovsek, Srdan
Published in Cancer (15.04.2022)
Published in Cancer (15.04.2022)
Get full text
Journal Article
Relevant Clinical Factors in Patients with Myelofibrosis on Ruxolitinib for 5 or More Years
Masarova, Lucia, Bose, Prithviraj, Pemmaraju, Naveen, Zhou, Lingsha, Pierce, Sherry, Estrov, Zeev, Kantarjian, Hagop, Verstovsek, Srdan
Published in Acta haematologica (01.11.2023)
Published in Acta haematologica (01.11.2023)
Get more information
Journal Article
Characteristics of patients with myelofibrosis on ruxolitinib for three or more years
Masarova, Lucia, Bose, Prithviraj, Pemmaraju, Naveen, Chifotides, Helen T., Zhou, Lingsha, Estrov, Zeev, Kantarjian, Hagop M., Verstovsek, Srdan
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Clinical Features Associated with Long-Term Ruxolitinib Exposure in Myelofibrosis and Predictive Role of Neutrophils
Masarova, Lucia, Bose, Prithviraj, Pemmaraju, Naveen, Zhou, Lingsha, Pierce, Sherry A., Estrov, Zeev E., Kantarjian, Hagop, Verstovsek, Srdan
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Long term follow-up results of phase II clinical trial evaluating ruxolitinib (RUX) and azacitidine (AZA) combination therapy in patients (pts) with myelofibrosis (MF)
Arora, Sankalp, Senapati, Jayastu, Masarova, Lucia, Pemmaraju, Naveen, Bose, Prithviraj, Bravo, Guillermo Montalban, Saenz, Dyana T, Halim, Habiba, Zhou, Lingsha, Maiti, Abhishek, Borthakur, Gautam, Kadia, Tapan M., Jabbour, Elias, Garcia-Manero, Guillermo, Kantarjian, Hagop M., Daver, Naval Guastad
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Prognostic value of blasts in peripheral blood in myelofibrosis in the ruxolitinib era
Masarova, Lucia, Bose, Prithviraj, Pemmaraju, Naveen, Daver, Naval G., Zhou, Lingsha, Pierce, Sherry, Sasaki, Koji, Kantarjian, Hagop M., Estrov, Zeev, Verstovsek, Srdan
Published in Cancer (01.10.2020)
Published in Cancer (01.10.2020)
Get full text
Journal Article
The role of therapy in the outcome of patients with myelofibrosis
Masarova, Lucia, Bose, Prithviraj, Pemmaraju, Naveen, Daver, Naval G., Sasaki, Koji, Chifotides, Helen T., Zhou, Lingsha, Kantarjian, Hagop M., Estrov, Zeev, Verstovsek, Srdan
Published in Cancer (15.09.2023)
Published in Cancer (15.09.2023)
Get full text
Journal Article
Impact of SF3B1 mutation on outcomes in myelofibrosis
Bose, Prithviraj, Senapati, Jayastu, Masarova, Lucia, Pemmaraju, Naveen, Bravo, Guillermo Montalban, Pierce, Sherry, Zhou, Lingsha, Garcia-Manero, Guillermo, Kantarjian, Hagop M., Verstovsek, Srdan
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Characteristics and Outcome of Myelofibrosis Patients on Long-Term Ruxolitinib Therapy (≥3 years)
Masarova, Lucia, Bose, Prithviraj, Pemmaraju, Naveen, Zhou, Lingsha, Pierce, Sherry A., Kantarjian, Hagop M., Estrov, Zeev E., Verstovsek, Srdan
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Improved Survival of Patients with Myelofibrosis in the Last Decade
Masarova, Lucia, Bose, Prithviraj, Pemmaraju, Naveen, Zhou, Lingsha, Pierce, Sherry A., Estrov, Zeev E., Kantarjian, Hagop M., Verstovsek, Srdan
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Clinical Significance of Bone Marrow Blast Percentage in Patients With Myelofibrosis and the Effect of Ruxolitinib Therapy
Masarova, Lucia, Bose, Prithviraj, Pemmaraju, Naveen, Daver, Naval, Zhou, Lingsha, Pierce, Sherry, Kantarjian, Hagop, Estrov, Zeev, Verstovsek, Srdan
Published in Clinical lymphoma, myeloma and leukemia (01.05.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.05.2021)
Get full text
Journal Article
Diploid Karyotype Represents a Favorable Prognostic Subgroup in Blast Phase Myeloproliferative Neoplasms
Venugopal, Sangeetha, Verstovsek, Srdan, Bose, Prithviraj, Pemmaraju, Naveen, Zhou, Lingsha, Pierce, Sherry A., Kantarjian, Hagop M., Estrov, Zeev E., Masarova, Lucia
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Outcomes of Patients with Myelofibrosis and Favorable Karyotype
Rivera, Daniel, Verstovsek, Srdan, Bose, Prithviraj, Pemmaraju, Naveen, Zhou, Lingsha, Pierce, Sherry A., Kantarjian, Hagop M., Estrov, Zeev E., Masarova, Lucia
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis
Masarova, Lucia, Verstovsek, Srdan, Hidalgo-Lopez, Juliana E., Pemmaraju, Naveen, Bose, Prithviraj, Estrov, Zeev, Jabbour, Elias J., Ravandi-Kashani, Farhad, Takahashi, Koichi, Cortes, Jorge E., Ning, Jing, Ohanian, Maro, Alvarado, Yesid, Zhou, Lingsha, Pierce, Sherry, Gergis, Romany, Patel, Keyur P., Luthra, Rajyalakshmi, Kadia, Tapan M., DiNardo, Courtney D., Borthakur, Gautam, Bhalla, Kapil, Garcia-Manero, Guillermo, Bueso-Ramos, Carlos E., Kantarjian, Hagop M., Daver, Naval
Published in Blood (18.10.2018)
Published in Blood (18.10.2018)
Get full text
Journal Article
Impact of SF3B1 mutation in myelofibrosis
Senapati, Jayastu, Verstovsek, Srdan, Masarova, Lucia, Pemmaraju, Naveen, Patel, Keyur P., Montalban-Bravo, Guillermo, Pierce, Sherry A., Zhou, Lingsha, Garcia-Manero, Guillermo, Kantarjian, Hagop M., Bose, Prithviraj
Published in Leukemia & lymphoma (19.09.2022)
Published in Leukemia & lymphoma (19.09.2022)
Get full text
Journal Article